Core facility News

  • Postdoc appreciation week: Nico Schramma in the spotlight
    Postdoc appreciation week: Nico Schramma in the spotlight During National Postdoc Appreciation Week, we are excited to shine a spotlight on the postdoctoral researchers at Amsterdam Cardiovascular Sciences. Today in the spotlight: Nico Schramma!
  • Check-up after high-risk colon polyps can be delayed by two years: just as safe, far less burdensome
    Check-up after high-risk colon polyps can be delayed by two years: just as safe, far less burdensome Patients whose high-risk colon polyps have been removed only need a follow-up colonoscopy after five years instead of three. Two large European studies, involving Amsterdam UMC, show this longer interval is just as safe — saving tens of thousands of colonoscopies in the Netherlands each year.
  • Can vitiligo enhance immunotherapy response in melanoma?
    Can vitiligo enhance immunotherapy response in melanoma? Melanoma patients who develop vitiligo during immunotherapy tend to have better outcomes. In the new IMMUNIZE-MI study, researchers at Cancer Center Amsterdam are testing whether deliberately inducing this immune response with topical MI therapy can strengthen standard immunotherapy. The study focuses primarily on safety and dose optimization, while searching for early signs of a stronger anti-tumor immune response.

Subscribe to our Newsletter

 Subscribe to our  Newsletter

All news from Core facility